AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Tocilizumab in Nigeria
4 products registered with NAFDAC — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Actemra 162 mg Solution for injection | A6-100070 | — | active | — |
| Actemra 200 mg Concentrate for solution for infusion | A6-100067 | — | active | — |
| Actemra 400 mg Concentrate for solution for infusion | A6-100066 | — | active | — |
| Actemra 80 mg Concentrate for solution for infusion | A6-100068 | — | active | — |
Tocilizumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 4 registered products containing Tocilizumab, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Tocilizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.